Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem ^® demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine

A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants

“…18 In most emerging and developing countries, DTP vaccination in infants. 7,[9][10][11] No study vaccine-related SAE or death was reported. The study demonstrated that Quinvaxem was immunogenic and well tolerated when administered to infants.…”